TFS Capital’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-34,107
Closed -$111K 119
2017
Q2
$111K Sell
34,107
-20,491
-38% -$66.7K 0.04% 536
2017
Q1
$248K Buy
+54,598
New +$248K 0.08% 418
2016
Q3
Sell
-20,925
Closed -$36K 817
2016
Q2
$36K Buy
+20,925
New +$36K 0.01% 927
2016
Q1
Sell
-32,495
Closed -$110K 1021
2015
Q4
$110K Sell
32,495
-88,656
-73% -$300K 0.01% 648
2015
Q3
$646K Buy
121,151
+39,354
+48% +$210K 0.06% 447
2015
Q2
$529K Buy
+81,797
New +$529K 0.05% 507